Literature DB >> 22461184

Causes and predictors of death in Brazilian lupus patients.

Rosa Weiss Telles1, Cristina Costa Duarte Lanna, Fabiana Lemos Souza, Luciana Andrade Rodrigues, Rodrigo Citton Padilha Reis, Antonio Luiz Ribeiro.   

Abstract

The objective of this study is to determine the causes and predictors of death in systemic lupus erythematosus (SLE) patients. Causes of death were defined based on death certificates, medical records, and information collected from doctors and relatives. Possible variables predicting mortality were assessed by Kaplan-Meier and Cox regression methods. The multivariate model was validated using the bootstrap method, and the hazard ratios were adjusted according to the shrinkage coefficient. One hundred eighty-one patients were included, and two patients were lost to follow-up. The median (IR) age at T (0) and disease duration of the 179 patients were 26.7 (21.8-34.6) and 8.2 (4.3-12.4) years, respectively. After a median (IR) follow-up of 3.3 (3.1-3.5) years, 13 (7.3 %) patients died due to end-organ failure (5), infection (5), disease activity (1), and atherosclerotic cardiovascular disease (CVD) (1). The cause of mesenteric ischemia in one patient could not be determined. Predictors of mortality collected at T(0) were the following: nephritis, chronic kidney disease, antiphospholipid syndrome (APS), higher modified SLEDAI-2k, higher damage index score, intravenous cyclophosphamide use, higher daily dose of prednisone, and higher systolic blood pressure. Independent predictors of mortality were higher damage index score (HR: 1.40; 95 % CI: 1.08-1.82), cyclophosphamide use (HR: 3.80; 95 % CI: 1.13-12.77), and APS diagnosis (HR: 3.82; 95 % CI: 1.07-13.59). This paper presents a high frequency of late mortality in lupus patients due to the SLE itself and infection. This result is not in agreement with the initial proposed bimodal pattern of lupus mortality, nor is it in agreement with the high frequency of CVD as a cause of death in developed countries. The most important predictors of death were related to the lupus itself.

Entities:  

Mesh:

Year:  2012        PMID: 22461184     DOI: 10.1007/s00296-012-2372-x

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  38 in total

Review 1.  Antiphospholipid antibodies and myocardial infarction.

Authors:  O Vaarala
Journal:  Lupus       Date:  1998       Impact factor: 2.911

2.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

Review 3.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

4.  Patterns of disease activity in systemic lupus erythematosus.

Authors:  S G Barr; A Zonana-Nacach; L S Magder; M Petri
Journal:  Arthritis Rheum       Date:  1999-12

5.  Long-term prognosis and causes of death in systemic lupus erythematosus.

Authors:  Andrea Doria; Luca Iaccarino; Anna Ghirardello; Sandra Zampieri; Silvia Arienti; Piercarlo Sarzi-Puttini; Fabiola Atzeni; Antonio Piccoli; Silvano Todesco
Journal:  Am J Med       Date:  2006-08       Impact factor: 4.965

6.  Antimalarial treatment may have a time-dependent effect on lupus survival: data from a multinational Latin American inception cohort.

Authors:  Samuel K Shinjo; Eloísa Bonfá; Daniel Wojdyla; Eduardo F Borba; Luis A Ramirez; Hugo R Scherbarth; João C Tavares Brenol; Rosa Chacón-Diaz; Oscar J Neira; Guillermo A Berbotto; Ignacio Garcia De La Torre; Eduardo M Acevedo-Vázquez; Loreto Massardo; Leonor A Barile-Fabris; Francisco Caeiro; Luis H Silveira; Emilia I Sato; Sandra Buliubasich; Graciela S Alarcón; Bernardo A Pons-Estel
Journal:  Arthritis Rheum       Date:  2010-03

Review 7.  Lupus in the developing world--is it any different?

Authors:  Mohammed Tikly; Sandra V Navarra
Journal:  Best Pract Res Clin Rheumatol       Date:  2008-08       Impact factor: 4.098

Review 8.  Infections as triggers and complications of systemic lupus erythematosus.

Authors:  A Doria; M Canova; M Tonon; M Zen; E Rampudda; N Bassi; F Atzeni; S Zampieri; A Ghirardello
Journal:  Autoimmun Rev       Date:  2008-08-12       Impact factor: 9.754

9.  Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients.

Authors:  Malik Anas Rabbani; H B Habib; M Islam; B Ahmad; S Majid; W Saeed; S M A Shah; A Ahmad
Journal:  Lupus       Date:  2009-08       Impact factor: 2.911

Review 10.  The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.

Authors:  D Gladman; E Ginzler; C Goldsmith; P Fortin; M Liang; M Urowitz; P Bacon; S Bombardieri; J Hanly; E Hay; D Isenberg; J Jones; K Kalunian; P Maddison; O Nived; M Petri; M Richter; J Sanchez-Guerrero; M Snaith; G Sturfelt; D Symmons; A Zoma
Journal:  Arthritis Rheum       Date:  1996-03
View more
  6 in total

1.  Clinicopathological and outcome analysis of adult lupus nephritis patients in China.

Authors:  Yi Tang; XiaoYan Zhang; Ling Ji; XuHua Mi; Fei Liu; LiChuan Yang; Wei Qin
Journal:  Int Urol Nephrol       Date:  2015-01-07       Impact factor: 2.370

2.  Survival analysis of patients with systemic lupus erythematosus in a tertiary hospital in southern Brazil.

Authors:  Jordana Vaz Hendler; Lucian de Souza; Daniele Corrêa de Freitas Zernow; Juliano Guimarães; Thiago Bertotto; Carla Forgiarini Saldanha; João Carlos Tavares Brenol; Odirlei André Monticielo
Journal:  Clin Rheumatol       Date:  2017-06-26       Impact factor: 2.980

3.  Association between organ damage and mortality in systemic lupus erythematosus: a systematic review and meta-analysis.

Authors:  Irene B Murimi-Worstell; Dora H Lin; Henk Nab; Hong J Kan; Oluwadamilola Onasanya; Jonothan C Tierce; Xia Wang; Barnabas Desta; G Caleb Alexander; Edward R Hammond
Journal:  BMJ Open       Date:  2020-05-21       Impact factor: 2.692

4.  Prevalence of hospital readmissions and related factors in patients with autoimmune diseases.

Authors:  Tatiana Morales-Tisnés; Lina Quintero-Ortiz; Elías Quintero-Muñoz; Fabio Sierra-Matamoros; Julián Arias-Aponte; Adriana Rojas-Villarraga
Journal:  J Transl Autoimmun       Date:  2021-09-08

5.  Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls.

Authors:  Irene E M Bultink; Frank de Vries; Ronald F van Vollenhoven; Arief Lalmohamed
Journal:  Rheumatology (Oxford)       Date:  2021-01-05       Impact factor: 7.580

Review 6.  The landscape of systemic lupus erythematosus in Brazil: An expert panel review and recommendations.

Authors:  Evandro Mendes Klumb; Morton Scheinberg; Viviane Angelina de Souza; Ricardo Machado Xavier; Valderilio Feijo Azevedo; Elizabeth McElwee; Mariana Rico Restrepo; Odirlei André Monticielo
Journal:  Lupus       Date:  2021-07-13       Impact factor: 2.911

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.